SHERMAN MATTHEW L (EVP & Chief Medical Officer) received a stock award from DECIPHERA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock
Shares
+34.16K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−72.03K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−72.26K
Price / share
—
Trade value
—
% of position
Net shares
−110.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2024 | A · Award | +34.16K | — | — | 31.0% | 110.13K | 144.29K |
| Common Stock Direct | 6/11/2024 | D · Disposition | −72.03K | — | — | 49.9% | 144.29K | 72.26K |
| Common Stock Direct | 6/11/2024 | U · U | −72.26K | — | — | New position | 72.26K | 0.00 |
| Total | −110.13K | $0.00 | ||||||
Stock Option (Right to Buy)
Common Stock
82.27K shares
Shares
−82.27K
Strike price
9.23
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
82K shares
Shares
−82K
Strike price
8.27
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
65.90K shares
Shares
−65.90K
Strike price
15.48
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
69.10K shares
Shares
−69.10K
Strike price
15.92
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock82.27K shares | 6/11/2024 | D · Disposition | −82.27K | 9.23 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock82K shares | 6/11/2024 | D · Disposition | −82K | 8.27 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock65.90K shares | 6/11/2024 | D · Disposition | −65.90K | 15.48 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock69.10K shares | 6/11/2024 | D · Disposition | −69.10K | 15.92 | — | 0.00 |